Alexander Kolevzon, MD
Icahn School of Medicine at Mount Sinai
13
11
9
N/A
0
8
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+3 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (13)
Showing 10 of 13 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Paige Siper, Ph.D.
Icahn School of Medicine at Mount Sinai
Shared therapeutic areas:
Worked with same sponsors:
Silvia De Rubeis, Ph. D.
Icahn School of Medicine at Mount Sinai
Shared therapeutic areas:
Worked with same sponsors:
Silvia De Rubeis, Ph.D.
Icahn School of Medicine at Mount Sinai
Shared therapeutic areas:
Worked with same sponsors:
Reymundo Lozano, M.D.
Icahn School of Medicine at Mount Sinai
Shared therapeutic areas:
Worked with same sponsors:
Dorothy Grice, M.D.
Icahn School of Medicine at Mount Sinai
Shared therapeutic areas:
Worked with same sponsors:
Elodie Drapeau, Ph.D.
Icahn School of Medicine at Mount Sinai
Shared therapeutic areas:
Worked with same sponsors:
Craig Erickson, MD
Children's Hospital Medical Center, Cincinnati
Shared therapeutic areas:
Worked with same sponsors:
Swathi Sethuram, MD
Icahn School of Medicine at Mount Sinai
Shared therapeutic areas:
Worked with same sponsors:
Randi Hagerman, MD
UC Davis MIND Institute
Shared therapeutic areas:
Worked with same sponsors:
Robert Findling, MD
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (13)
Showing 13 of 13 trials
A Controlled Trial of Growth Hormone in Phelan-McDermid Syndrome and Idiopathic Autism
Low-Dose Ketamine in Children With ADNP Syndrome
Growth Hormone Treatment in Children With Phelan McDermid Syndrome
AMO-01 to Treat Adolescents and Adults With Phelan-McDermid Syndrome (PMS) and Co-morbid Epilepsy
DDX3X Syndrome -The Seaver Autism Center for Research and Treatment is Characterizing DDX3X-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures.
ADNP Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing ADNP-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures.
FOXP1 Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing FOXP1-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures.
Clinical Trial in 22q13 Deletion Syndrome(Phelan-McDermid Syndrome)
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Pilot Treatment Study of Insulin-Like Growth Factor-1 (IGF-1) in Autism Spectrum Disorder
Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid Syndrome
Piloting Treatment With Intranasal Oxytocin in Phelan-McDermid Syndrome
All 13 trials loaded